Clinical Trials in Miami

Showing 641-660 of 5,521 trials

A Study to Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Severe Renal Impairment Compared to Matched Healthy Participants.

NCT07032272

The purpose of this study is to support the development of remibrutinib dosing recommendations for patients with impaired renal function.

Autoimmune and Chronic Inflammatory Diseases

Novartis Pharmaceuticals16 participantsStarted Jul 2025

Miami, Florida, United States • Miami Lakes, Florida, United States • Orlando, Florida, United States +1 more locations

RECRUITINGNA< 1 mile

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

NCT06983041

The objective of this study is to determine clinical cure rate and safety of a proprietary Vaginal Cooling Device (VCD) in women with VCC. In addition, the safety, mycological cure rates, the speed and efficacy of symptom resolution, vaginal hyphae and polymorphonuclear (PMN) scores, and Quality-of-Life (QoL) parameters will be determined.

Vulvovaginal Candidiasis (VVC)Yeast Vaginitis

Coologics, Inc55 participantsStarted May 2025

Jacksonville, Florida, United States • Miami, Florida, United States • Smyrna, Georgia, United States +7 more locations

A Study to Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Severe Renal Impairment Compared to Matched Healthy Participants.

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

Find Trials by Condition in Miami

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis

Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 50 Years of Age With Non-congenital Myotonic Dystrophy Type 1

Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer

Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)

A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer